ALLO
Allogene Therapeutics, Inc. · Healthcare
President and CEO David D Chang sold $118K of Allogene Therapeutics, Inc.
Sold$117,975
$2.47Price
47,763Shares
−1%Stake
What ALLO did after the filing
- The stock from Wed, Mar 18 close, $2.15
- −0.9%
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Apr 30 close.
Traded Mon, Mar 16. Filed Wed, Mar 18, 12:05 PM ET, during the session. Returns use the Mar 18 close and the Apr 30 close. Not investment advice.